FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EPITOL (carbamazepine) filed by Teva Pharmaceuticals USA, Inc., under ANDA070541.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Trigeminal Neuralgia

Drugs mentioned

• EPITOL (carbamazepine)

Snippet

SUPPL AP for EPITOL (CARBAMAZEPINE)